ALIOF (ALIOF) Stock Price, News & Analysis

Company Overview

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

Key Stats

• Today's Range: $278.50 to $278.50
• 50-Day Range: $278.50 to $278.50
• 52-Week Range: $138.01 to $286.30
• Volume: N/A
• Average Volume: 924 shs
• Market Capitalization: $29.89 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALIOF Stock Analysis - Frequently Asked Questions

How have ALIOF shares performed this year?

ALIOF's stock was trading at $278.50 at the start of the year. Since then, ALIOF stock has increased by 0.0% and is now trading at $278.50.
View the best growth stocks for 2025 here.

How were ALIOF's earnings last quarter?

ALIOF (OTCMKTS:ALIOF) posted its quarterly earnings data on Monday, February, 16th. The company reported $0.87 EPS for the quarter, missing the consensus estimate of $1.09 by $0.22. The business earned $501.50 million during the quarter, compared to the consensus estimate of $546.30 million.

How do I buy shares of ALIOF?

Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/16/2015
• Today: 5/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medicinals & Botanicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ALIOF
• CIK: N/A
• Web: www.actelion.com
• Phone: (161) 565-6565
• Fax: 41-61-565-6500
• Employees: N/A
• Year Founded: 1997

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 107,330,000
• Free Float: N/A
• Market Cap: $29.89 billion
• Optionable: Not Optionable
• Beta: N/A